Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Preclinical Cardiotoxicity Screening in Cardio-Oncology

JACC CardioOncol. 2024 Sep 10;6(5):678-683. doi: 10.1016/j.jaccao.2024.07.012. eCollection 2024 Oct.

Authors

Kyle D Shead¹, Eline Huethorst¹, Francis Burton¹, Ninian N Lang¹, Rachel C Myles¹, Godfrey L Smith¹

Affiliation

¹ School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom.

No abstract available

Keywords: anticancer therapy; cardiotoxicity; hiPSC cardiomyocytes.

Publication types

Review